Figure 1.

Cumulative incidence for composite cardiovascular outcome and HHF comparing PS-matched SGLT2i vs. GLP-1RA initiators overall and by history of CVD. ¹Hospitalization for myocardial infarction, ischemic or hemorrhagic stroke, or cardiovascular mortality. ²History of CVD is defined as history of myocardial infarction, unstable angina, coronary atherosclerosis and other forms of chronic ischemic heart disease, coronary procedure, heart failure, ischemic or hemorrhagic stroke, transient ischemic attack, peripheral arterial disease or surgery, or lower-extremity amputation. Data are n unless otherwise indicated.